Informazioni sul prodotto
- D-Phenylalaninamide, (3R)-3-(1,3-benzodioxol-5-yl)-N-[(6-methoxy-2-naphthalenyl)sulfonyl]-β-alanyl-4-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]methyl]-N-methyl-N-(1-methylethyl)-, hydrochloride (1:1)
- D-Phenylalaninamide, (3R)-3-(1,3-benzodioxol-5-yl)-N-[(6-methoxy-2-naphthalenyl)sulfonyl]-β-alanyl-4-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]methyl]-N-methyl-N-(1-methylethyl)-, monohydrochloride
SSR 240612 is a novel drug that has been shown to be effective in the treatment of bowel disease and solid tumours. It is an inhibitor of fatty acid synthase, which is involved in the synthesis of long-chain fatty acids. SSR 240612 also inhibits acetylcholine release by binding to muscarinic receptors, leading to its anti-inflammatory effect. SSR 240612 may also have anticancer activity because it inhibits histone deacetylases and polymerase chain reaction (PCR) amplification of malignant brain cells.
Proprietà chimiche
Richiesta tecnica su: 3D-PTA93042 SSR 240612
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
